Morgan Stanley’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Sell |
|
|||||
|
2025
Q1 | $4.22M | Buy |
|
|||||
|
2024
Q4 | $4.51M | Sell |
|
|||||
|
2024
Q3 | $4.42M | Buy |
|
|||||
|
2024
Q2 | $3.04M | Sell |
|
|||||
|
2024
Q1 | $11.8M | Buy |
|
|||||
|
2023
Q4 | $9.67M | Buy |
|
|||||
|
2023
Q3 | $3.93M | Sell |
|
|||||
|
2023
Q2 | $6.41M | Buy |
|
|||||
|
2023
Q1 | $3.47M | Buy |
|
|||||
|
2022
Q4 | $1.88M | Sell |
|
|||||
|
2022
Q3 | $4.54M | Sell |
|
|||||
|
2022
Q2 | $3.02M | Sell |
|
|||||
|
2022
Q1 | $4.95M | Buy |
|
|||||
|
2021
Q4 | $632K | Buy |
|
|||||
|
2021
Q3 | $276K | Buy |
|
|||||
|
2021
Q2 | $149K | Buy |
|